Howard M Belmont MD

PubMed

• Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials.
  Amit Saxena, Cristina Sorrento, Peter Izmirly, Janine Sullivan, Monica Gamez-Perez
  Lupus Science & Medicine. 2025-01-06
• 3 citations
  Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program.
  Ghadeer Hasan, Elizabeth D Ferucci, Jill P Buyon, H Michael Belmont, Jane E Salmon
  Rheumatology. 2023-08-01
• 6 citations
  Fluctuation of Anti-Domain 1 and Anti-β-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies.
  Cecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, Maria Tektonidou, Vittorio Pengo
  Arthritis & Rheumatology. 2023-06-01

Journal Articles

• Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...  
  Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
• Anal squamous cell carcinoma in two intravenous cyclophosphamide treated systemic lupus patients with human papilloma virus infection  
  Lydon EJ, Belmont HM, Lydon EJ, Belmont HM, 7/26/2013
• Treatment of Systemic Lupus Erythematosus:2013  
  Belmont HM, Update Bulletin of NYU Hospital for Joint Diseases, 1/1/2013
• Pseudo-pseudo Meigs' syndrome in a patient with systemic lupus erythematosus  
  Dalvi S, Yildirim S, Santoriello D, Belmont HM, Lupus, 9/14/2012
• J International consensus for a definition of disease flare in lupus  
  Ruperto N, Hanrahan L, Alarcon G, Belmont HM, Brey R, et al, Lupus, 12/1/2010
• Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease  
  Reiss AB, Anwar K, Merrill JT, Chan ES, Awadallah NW, Cronstein BN, Belmont HM, Belilos E, Rosenblum G, Belostocki K, Bonetti L, Hasneen K, Carsons SE, Rheumatol Int, 6/23/2009
• Three-dimensional electrocardiographically gated variable flip angle FSE imaging for MR angiography of the hands at 30 T: initial experience  
  Lim RP, Storey P, Atanasaova IP, Xu J, Hecht E, Babb D, Stoffel D, Chang H, McGorty K, Chen Q, Rusinek H, Belmont HM, MD, Lee VS, Radiology, 6/1/2009
• Current therapies for lupus nephritis in an ethnically heterogenous cohort  
  Rivera TL, Belmont HM, Malani S, Latorre M, Weisstuch J, Barison L, Tseng CE, Izmirily P, Buyon JP, Askanase AD, J Rheumatology, 1/1/2009
• Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus  
  Kishimoto M, Nasir A, Mor A, Belmont HM, Lupus, 1/1/2007
• Randomized, double-blind, placebo-controlled trial The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but c...  
  Tseng CE, Buyon JP, Kim M, Belmont HM, et al, Arthritis Rheum, 10/1/2006
• Avascular necrosis prevention with lipitor in lupus erythematosus  
  Belmont, HM, Lydon E, Lupus, 1/1/2005
• Aplastic anemia in SLE  
  Belmont HM, Tagoe C, Journal of Clinical Rheumatology, 12/1/2001
• Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure  
  Neamtu, L., Belmont, HM., Miller, D.C., Leroux, P, Weinberg, H., Zagzag, D, Neurology, 1/1/2001
• Initial management of proliferative lupus nephritis: to cytotoxic or not to cytotoxic?  
  Belmont HM, Current Rheumatology Reports, 1/1/1999
• SLE: Mechanisms of Vascular Injury  
  Belmont, HM, Abramson S, Hospital Practice, 1/1/1998
• The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al  
  Golden BD, Belmont HM, Arthritis Rheum, 1/1/1997
• Enterococcal arthritis with avascular necrosis in a lupus patient  
  Markov G, Dobro J, Shankman S, Belmont HM, British Journal of Rheumatology, 1/1/1996
• Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium  
  Belmont HM, Abramson S, Lie JT, Arthritis and Rheumatism, 1/1/1996
• NYU/HJD experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis  
  Belmont HM, Storch M, Buyon J, Abramson S, Lupus, 1/1/1995
• Quantitative EEG: A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus  
  Ritchlin C, Chabot R, Alper K, Buyon J, Belmont HM, Abramson, S, Arthritis and Rheumatism, 1/1/1992
• Complement determinations: Clinical utility in systemic lupus erythematosus  
  Belmont HM, Mediguide to Inflammatory Diseases, 1/1/1991
• Lupus psychosis  
  Belmont HM, Abramson S, New England Journal of Medicine, 1/1/1988
• Complement activation and vascular injury in systemic lupus erythematosus  
  Abramson S, Belmont HM, Hopkins P, Buyon J, Winchester B, and Weissmann G, Journal of Rheumatology, 1/1/1987
• Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerbation of disease  
  Belmont, HM. Edelson H, Kaplan H, Ludwig R, Weissmann G, and Abramson S, Arthritis and Rheumatism, 1/1/1986
• Serum sickness  
  Belmont, HM, New England Journal of Medicine, 1/1/1985
• Join now to see all

Books/Book Chapters

• UpToDate 
  Chapter: Pharmacology and side effects of azathioprine when used in rheumatic diseases 
  Belmont HMEditors: Furst D, Romain P.2013
• Challenging Cases in Allergy and Immunology 
  Chapter: Immune Mediated Rheumatic Diseases 
  Belmont HMEditors: Massoud Mahmoudi.Humana Press2009
• Vascular Manifestations of Systemic Autoimmune Diseases 
  Chapter: Systemic inflammatory response syndrome, systemic lupus erythematosus and thrombosis 
  Belmont HM, Abramson SEditors: Asherson, Cervera, Tripplet, and Abramson.CRC Press, Chicago, IL2001
• Hughes Syndrome 
  Chapter: Catastrophic antiphospholipid Syndrome 
  Belmont HMEditors: Hughes G. & Khamashta M.2000
• Molecules & Cellular Basis of Inflammation 
  Chapter: Lupus erythematosus: the role of adhesion molecules and local mediators 
  Belmont HM, Abramson SEditors: Serhan.1999
• Lupus: Molecular & Cellular Pathogenesis 
  Chapter: Nitric oxide in SLE: Implications for immunity and inflammation 
  Belmont HM, Amin A, Abramson SEditors: Kammer.1999
• Dubois Lupus Erythematosus 
  Chapter: Mechanisms of Acute Inflammation in SLE 
  Belmont HM, Abramson SEditors: Wallace and Hahn.Edition 5th,1997
• Current Diagnosis 
  Chapter: Systemic Lupus Erythematosus 
  Belmont HM1996
• Join now to see all

Abstracts/Posters

• Long term follow-up of AVN natural history in cohort of SLE patients randomized to atorvostatin during high dose treatment
  Lydon E, Belmont HM, Arthritis and Rheumatism, 1/1/2013
• Favorable response to belimumab at three months
  Shum K, Buyon JP, Belmont HM, Askanese A, Arthritis and Rheumatism, 1/1/2012
• HPV as a Risk Factor for Perianal Squamous Cell Carcinoma in Systemic Lupus Erythematosus
  Lydon E, Belmont HM, Arthritis and Rheumatism, 1/1/2010
• Identification of Cardiac Risk Factors in Hospitalized Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
  Lydon E, Belmont HM, Arthritis and Rheumatism, 1/1/2009
• Widespread up-regulation of membrane endothelial protein c receptor in a subset of patients with active lupus nephritis
  Izmirly P, Yee H, Rivera T, Belmont HM, Tseng CE, Esmon C, Braun A, Askanase A, Ginzler EM, Buyon J, Clancy, R, Arthritis and Rheumatism, 1/1/2008
• Expression of Endothelial Protein C Receptor (EPCR) in Peritubular Capillaries (PTC) of Renal Cortex Reflects Thwarted Cytoprotection and Associates with Progression o...
  Izmirily P, Barisoni L, Rivera T, Weisstuch J, Liu D, Belmont HM, Tseng CE, Askanase A, Buyon J, Arthritis and Rheumatism, 1/1/2007
• Atherogenic properties of lupus plasma: increased foam cell transformation and CD36 scavenger receptor and diminished cholesterol 27-hydroxylase
  Reiss AB, Wan DW, Merill JT, Zhang H, Chan L, Rao S, Belilos E, Belmont HM et al, Arthritis and Rheumatism, 1/1/2006
• Cyclosphosphamide (CYT) Administration in the Treatment of SLE: “Best Practices Survey”
  Lydon E, Izmirly P, Belmont HM, Arthritis and Rheumatism, 1/1/2005
• Combined Oral Contraceptives (OC) are not associated with an Increased Rate of Flare on SLE Patients in SELENA.
  Petri M, Buyon, JP, Kim M, Kalunian K, Grossman J, Hahn B, Sammaritano L, Lokshin M, Merrill J, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley M, Von Feld..., Arthritis and Rheumatism, 1/1/2004
• Inhibition of Expression of the Anti-atherogenic Cholesterol 27-Hydroxylase in Human Monocytoid Cells Exposed to SLE Patient Serum is Abrogated by Blocking the Interfe...
  Reiss A, Merrill J, Rahman M, Hasneen K, Chan E, Belmont HM, Khoa N, Crostein B, Arthritis and Rheumatism, 1/1/2003
• C3, C4, CH50, anti-dsDNA Antibodies and C3a Complement Split Products are Specific but not Sensitive for Predicting Flares of Systemic Lupus (SLE)
  Tseng C, Abramson S, Kim M, Belmont, HM, Haines K, Petri M, Buyon J, Arthritis and Rheumatism, 1/1/2002
• Prevalence of coronary artery disease risk factors and safety of HMG-COA reductase and COX-2 inhibitors in an active SLE population
  Gross M, Rozycki MJ, Belmont HM, Arthritis and Rheumatism, 1/1/2000
• Elevations of either anti-DNA antibodies or C3a alone are not predictive of severe flares of Systemic Lupus Erythematosus (SLE)
  Tseng C, Buyon J, MacKay M, Rosenthal P, Gross M, Ilie V, Belmont HM, Kim M, Neiman A, Haines K, Abramson S, Arthritis and Rheumatism, 1/1/2000
• Circulating activated endothelial cells in SLE: Further evidence for diffuse vasculopathy
  Marder G, Buyon J, Belmont HM, Abramson S, Clancy R, Arthritis and Rheumatism, 1/1/1999
• Flares in the SELENA hormone replacement trial
  Petri M, Buyon J, for the SELENA Group (Belmont HM, Dooley MA, Grossman J, Hahn B, Hearth-Holmes M, Kalunian K, Kim M, Lockshin M, Manzi S, McCune J, Merrill J, Samma..., Arthritis and Rheumatism, 1/1/1999
• Biochemical markers of coagulation with estrogen exposure in systemic lupus erythematosus
  Petri M, Buyon J, Magder L, for the SELENA Group (Alarcon G, Belmont HM, Dooley MA, Grossman J, Hahn B, Hearth-Holmes M, Kalunian K, Kim M, Lockshin M, Manzi S, McCune..., Arthritis and Rheumatism, 1/1/1999
• The effect of menopausal status and exogenous estrogen on homocysteine in systemic lupus erythematosus
  Petri M, Buyon J, Magder L, Roubenoff R, Selhub J, for the SELENA Group (Alarcon G, Belmont HM, Dooley MA, Grossman J, Hahn B, Hearth-Holmes M, Kalunian K, Kim M, Lock..., Arthritis and Rheumatism, 1/1/1999
• Reliability of SELENA SLEDAI and flare as clinical trial outcome measures
  Petri M, Buyon J, Skovron ML, Kim M for the SELENA Study group (Belmont HM, Hahn B, Kalunian K, Lahita R, Locksin M, Merrill J, Sammaritano L), Arthritis and Rheumatism, 1/1/1998
• Decreased anticoagulant protein S and the homologous sex hormone binding globulin in patients enrolled in the SELENA (Estrogen Safety) Study
  Merill J, Schappert J, Shriky R, Zhang HW, Petrie M, and Buyon J for SELENA Group): (Kalunian K, Belmont HM, Sammaritano L, Hahn B, Lahita R), Arthritis and Rheumatism, 1/1/1998
• Cutaneous SLE: relationship between serum Ro/La autoantibody profiles and Ro/La antigen expression in keratinocytes
  Golden B, Tseng C, Belmont HM, Buyon J, Arthritis and Rheumatism, 1/1/1996
• Prospective study of hydroxychloroquine effect on serum lipids in patients with SLE and rheumatoid arthritis
  Belmont HM, Kitsis E, McCullagh E, Skovron ML, Abramson S, Arthritis and Rheumatism, 1/1/1995
• Increased serum nitrite levels in lupus pregnancies
  Buyon J, Seligman S, Clancy r. Belmont HM, Young B, Abramson S, Arthritis and Rheumatism, 1/1/1994
• Past and present use of oral contraceptives and estrogen replacement therapy in women with SLE
  Buyon J, Abramson S, Belmont HM, Arthritis and Rheumatism, 1/1/1993
• Cardiac risks factors in patients with systemic lupus erythematosus
  Kitsis E, Belmont HM, Skovron M, Ornstein H, McCullagh E, Peter J, Abramson S, Arthritis and Rheumatism, 1/1/1992
• Quantitative EEG in patients with Systemic Lupus Erythematosus (SLE) and neuropsychiatric dysfunction
  Ritchlin C, Chabot R, Roubey R, Dwyer E, Eberle M, Sulkowitz K, Buyon J, Belmont HM, Abramson S, Arthritis and Rheumatism, 1/1/1989
• Join now to see all